Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Acreage Holdings Inc C.ACRG.A.U

Alternate Symbol(s):  ACRHF | ACRDF | C.ACRG.B.U

Acreage Holdings, Inc. is a vertically integrated, multi-state operator in the United States cannabis industry. The Company’s operations include cultivating and processing cannabis plants, manufacturing branded consumer products, distributing cannabis flower and manufactured products, and retailing dosable cannabis products to consumers. It is offering a range of products from its flagship brand, The Botanist, for adult-use sales in New Jersey. It has also launched Botanist Vape Cartridges and Disposables in Illinois, as well as Superflux Cured Concentrates. Its brand also includes Prime Wellness. It owns and operates eight cultivation and processing facilities, one each in Illinois, Maine, New Jersey, New York, Ohio, and Pennsylvania, respectively, and two in Massachusetts. The Company also owns 23 operational dispensaries in seven states. Its subsidiary, Universal Hemp, LLC, distributes, markets, and sells cannabidiol products.


CSE:ACRG.A.U - Post by User

Post by geodcanon Dec 16, 2021 2:06pm
227 Views
Post# 34237768

I have grave concerns that

I have grave concerns thatthese guys are going to try to fleece this lamb twice.  Canopy just stated that they are dumping out C3 co. GMBH and the market construed it as costing Canopy to do so, a rather large amount but they suggest that it will save a ton of development funds and it is no big deal because Canopy is developing its own line of pharma intentioned products.

In my mind, I believe that Canopy needs what Acreage brings to the deal but with the shareprice getting hammered down to these levels, the math suggests that Canopy can just go to the market at current prices and grab full control, on sale, as in cheaper than what they expected it to cost when they revisited the deal and came up with a huge discount with little respect for shareholders that are long term and severely under water for their support.

Canopy doesn't have to do the deal with Acreage, although it would be dirty pool to fock over shareholders twice but they have TER and probably others that bring a lot of what Acreage brings.

Acreage is probably the worst performing US MSO in the market even though they are grinding it towards a good balance sheet.

Clearly, all of the potpreneurs are hanging their hopes on some kind of a "triggering event" that will get International investors feeling unpersecuted by US business and politicians to the degree that they will plant their flags on US soil without fear of being singled out by the Feds.

The US MSOs are willing to work with the way it is set up right now, with the handshake kind of a deal such that the Feds will let the individual States administer their own justice if their workarounds draw fire.

I have no fear that Canopy is still a leadership contender because they have secured financial backing from Constellation who I believe will go to the wall to protect their first $5 billion share purchase despite the short term negative bottomline incurred by Canopy on Canadian soil where politics are depressing real potential for potpreneurs wanting to do business on Canadian soil.

As an early investor in Acreage, my sentiment is that revisiting the deal they had inked with Canopy was a major fock-over for the first string of investors and tainted Canopy as a dirty inside trader and took potential straight out of shareholders accounts.

Where this winds up is up to management of both parties to the deal that is inked and it comes down to integrity and trust that shareholders get put first.

glta and dyodd
<< Previous
Bullboard Posts
Next >>